We proudly present the new external quality assessment program for 2025. The program includes over 180 clinically relevant external quality assessment schemes and fully complies with ISO 15189 standard requirements. The 2025 product catalogue introduces five new EQA schemes.
Labquality provides clinically relevant EQA programmes to support continuous quality improvements for the benefit of patients. Labquality’s external quality assessment program is aimed at medical laboratories and point-of-care testing sites.
New schemes and products
- 5850 Brucella antibodies
- 5687 HBsAg and HCVAb POCT
- 5251 Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis - whole blood sample
- 5686 Norovirus, antigen detection
- 2755 Holotranscobalamin (HoloTC) and Methylmalonic Acid
We will announce the contents and schedules of pilot schemes later. Pilot schemes are EQA schemes under our product development.
